When patients switched to either fostemsavir or the combination of dolutegravir/lamivudine (DTG/3TC), suppression was maintained in most patients. Both dolutegravir ...
Newborns remain one of the most overlooked populations in the fight against HIV, with an estimated 120,000 new infections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback